RBC Capital Maintains Outperform on Cardinal Health, Raises Price Target to $295
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsPrice TargetHot
RBC Capital analyst Ryan Halsted maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $276 to $295.
RBC Capital analyst Ryan Halsted maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $276 to $295.